ClinicalMetric / Countries / Japan / attention deficit hyperactivity disorder adhd
← 🇯🇵 Japan Trials
🇯🇵 Japan Country × Condition

attention deficit hyperactivity disorder adhd Clinical Trials in Japan

Active clinical trials for attention deficit hyperactivity disorder adhd with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 3 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇯🇵 Japan

Active Trials in Japan (1)

NCT07087327 Phase 3
Recruiting

A Long-term Trial of EB-1020 in Pediatric Patients With ADHD

Enrollment
180 pts
Country
🇯🇵 Japan
Otsuka Pharmaceutical Co., Ltd.
View Trial →

Frequently Asked Questions

How many attention deficit hyperactivity disorder adhd clinical trials are active in Japan?
There are currently 1 active clinical trials for attention deficit hyperactivity disorder adhd with sites in Japan, of which 1 are actively recruiting patients.
How can I join a attention deficit hyperactivity disorder adhd clinical trial in Japan?
To join a attention deficit hyperactivity disorder adhd clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are attention deficit hyperactivity disorder adhd trials in Japan?
Active attention deficit hyperactivity disorder adhd trials in Japan span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Japan Trials → Global attention deficit hyperactivity disorder adhd Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology